Article
Genetically informed prioritization of immune checkpoint-associated genes in head and neck cancer highlights HGF and AKT1.
Functional & integrative genomics - 23 Sept 2026
Zheng Mengjie, Zhu Hao, Kong Jun, Zhang Li
Abstract excerpt
Immune checkpoint inhibitors are used to treat head and neck cancer (HNC), but clinical responses vary, and systematic genetic evaluation is needed to prioritize candidate susceptibility genes. We applied summary-data-based Mendelian randomization (SMR) and HEIDI testing to screen 624 immune checkpoint-related genes, integrating GWAS data from the Million Veteran Program with blood-derived multi-omics QTLs, and...
Read the complete abstract on PubMedTopics
- Humans
- Proto-Oncogene Proteins c-akt
- Hepatocyte Growth Factor
- Head and Neck Neoplasms
- Quantitative Trait Loci
- Genome-Wide Association Study
